Aims and scope
BMJ Open Ophthalmology is the online-only, open access companion to British Journal of Ophthalmology. The journal publishes high quality, peer-reviewed articles on basic, translational and clinical science, covering all aspects of ophthalmology and vision science.
BMJ Open Ophthalmology aims to:
- Publish a broad range of articles of particular clinical, scientific, educational or surgical value on a rapid publication schedule
- Facilitate a close interaction between basic, translational and clinical sciences through publication and fostering interdisciplinary research
- Provide an interactive digital platform that is freely available, unrestricted and immediately accessible
- Provoke scientific debate and clinical commentary in which the readership, authors and public can engage and contribute through social media and multimedia
BMJ Open Ophthalmology is owned by BMJ.
|Publication Model||Open access|
|Frequency||Continuous online publication|
|Indexed by||Web of Science Core Collection: Emerging Sources Citation Index, PubMed Central, DOAJ, Google Scholar|
|Peer review model||Single blind; the names of reviewers are hidden from the author|
The British Journal of Ophthalmology is an international peer-reviewed journal for ophthalmologists and visual science specialists. British Journal of Ophthalmology publishes clinical investigations, clinical observations, and clinically relevant laboratory investigations related to ophthalmology. It also provides major reviews and also publishes manuscripts covering regional issues in a global context. British Journal of Ophthalmology is owned by BMJ.
The BMJ is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.
The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting accurate, transparent reporting of research studies. The BMJ Group is a sponsor of its activities.